Corient Private Wealth
AMED

Corient Private Wealth’s Amedisys AMED Stock Holding History

Corient Private Wealth’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,144
Closed -$211K – 2557
2025
Q2 		$211K Buy
+2,144
New +$203K ﹤0.01% 2211

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Corient Private Wealth's AMED Position: Q3 2025 in Review

Corient Private Wealth sold out of Amedisys (AMED) in Q3 2025, closing a stake of 2,144 shares — an estimated $211K sold.

Corient Private Wealth first reported a position in AMED in Q2 2025 and held it in 1 quarter. The position peaked at $211K in Q2 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Corient Private Wealth reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Corient Private Wealth sold 2,144 Amedisys shares in Q3 2025, an estimated $211K.
  • Corient Private Wealth first reported a position in Amedisys in Q2 2025 and held it in 1 quarter.
  • Corient Private Wealth's Amedisys position peaked at $211K in Q2 2025.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Corient Private Wealth's 13F filing for Q3 2025, filed 14 Nov 2025.